Co-administration of memantine and amantadine with sub/suprathreshold doses of L-Dopa restores motor behaviour of MPTP-treated mice

Experimental Design: Procedures for the Behavioral Sciences

2013 • 8,527 citations

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.

1986 • 1,814 citations

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

1998 • 504 citations

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents — preclinical studies

1997 • 317 citations

NMDA antagonists potentiate antiparkinsonian actions of <scp>L</scp>‐dopa in monoamine‐depleted rats

1990 • 285 citations

Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.

1994 • 283 citations

Patch clamp studies on the kinetics and selectivity of N-methyl-d-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan)

1993 • 278 citations

Mechanism of memantine block of NMDA‐activated channels in rat retinal ganglion cells: uncompetitive antagonism.

1997 • 275 citations

The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice

1986 • 211 citations

Wearing‐off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanisms

1994 • 155 citations

Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and l-DOPA administration

1998 • 149 citations

Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease

1994 • 147 citations

Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease

1990 • 145 citations

Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse

1989 • 141 citations

Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease

1992 • 137 citations

Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression.

1992 • 128 citations

Dopamine/glutamate interactions in Parkinson's disease

1997 • 127 citations

Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease

1998 • 123 citations

I. MPTP neurotoxicity: An overview and characterization of phases of toxicity

1985 • 119 citations

NMDA receptor blockade reverses motor response alterations induced by levodopa

1994 • 112 citations

Behavioural pharmacology of glutamate receptors in the basal ganglia

1997 • 111 citations

Comparative Patch‐clamp Studies with Freshly Dissociated Rat Hippocampal and Striatal Neurons on the NMDA Receptor Antagonistic Effects of Amantadine and Memantine

1996 • 107 citations

Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade

1995 • 106 citations

Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.

1991 • 100 citations

MPTP-induced behavioural and biochemical deficits: A parametric analysis

1994 • 84 citations

Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease

1997 • 82 citations

MPTP‐Induced Hypoactivity in Mice: Reversal by L‐Dopa

1990 • 80 citations

Are NMDA antagonistic properties relevant for antiparkinsonianlike activity in rats?—Case of amantadine and memantine

1994 • 75 citations

Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801

1992 • 60 citations

L-Dopa in Parkinsonism and the Influence of Previous Thalamotomy

1971 • 53 citations

Amantadine and Motor Fluctuations in Chronic Parkinsonʼs Disease

1987 • 49 citations

Further Studies on the Mode of Action of Amantadine

1971 • 49 citations

Memantine, amantadine, and L-deprenyl potentiate the action of L-DOPA in monoamine-depleted rats

1994 • 43 citations

Dopamine disease states

1996 • 38 citations

Dissociation between biochemical and behavioral recovery in MPTP-treated mice

1989 • 38 citations

Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic l-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat

1998 • 34 citations

Derivatives of cis-2-Amino-8-hydroxy-1-methyltetralin: Mixed 5-HT1A-Receptor Agonists and Dopamine D2-Receptor Antagonists

1995 • 34 citations

Dopamine agonists potentiate antiakinetic effects of competitive NMDA-antagonists in monoamine-depleted mice

1991 • 33 citations

Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity

1993 • 33 citations

Neuroprotective Properties of the Uncompetitive NMDA Receptor Antagonist Remacemide Hydrochloride

1995 • 30 citations

Effect of coadministration of glutamate receptor antagonists and dopaminergic agonists on locomotion in monoamine-depleted rats

1995 • 30 citations

Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: effects of glutamate antagonists

1999 • 28 citations

Synergistic interactions between NMDA-antagonists and L-Dopa on activity in MPTP-treated mice

1994 • 23 citations

Effects of co-administration of anticonvulsant and putative anticonvulsive agents and sub-/suprathreshold doses of L-Dopa upon motor behaviour of MPTP-treated mice

1999 • 14 citations

Effect of the competitive NMDA antagonist, CGP 40 116, and a low dose of L-Dopa on the motor activity deficit of MPTP-treated mice

1994 • 12 citations

Synergistic interactions between the NMDA antagonist dizocilpine and the preferential dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 with regard to locomotor stimulation in monoamine-depleted mice

1991 • 11 citations

Amantadine attenuates response alterations resulting from repetitive L-DOPA treatment in rats

1998 • 8 citations

Dopaminergic-glutamatergic balance in the forebrain: functional studies of movement disorders in rats and mice. In: Palomo T, Archer T, Beninger RJ, editors. Dopamine disease states.

1996 • 8 citations

Effects of acute/chronic, subthreshold/threshold doses of L-Dopa in MPTP-treated mice: In:T. Palomo, R.J.Beninger a T. Archer (eds) Interactive monoaminergic Basis of Brain Disorders.

1998 • 6 citations

Effect of amantadine on some psychomotor performances in Parkinsonism. A double blind study.

1971 • 3 citations

[Amantadine therapy in parkinsonism].

1972 • 2 citations